Bethany Mills
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bethany Mills has a total of 220 co-authors. Here are the top co-authors by number of shared publications:
- Kevin Dhaliwal
University of Edinburgh
17 shared publications - Mark Bradley
Precision Healthcare University Research Institute, Queen Mary University of London, Empire House, London, UK
15 shared publications Kevin Dhaliwal
Translational Healthcare Technologies, Centre for Inflammation Research, Edinburgh Medical School, The University of Edinburgh, Edinburgh, U.K.
10 shared publications- Michael George Tanner
Institute of Photonics and Quantum Sciences Heriot‐Watt University Edinburgh UK
9 shared publications - Alicia Megia-Fernandez
School of Chemistry, University of Edinburgh, Edinburgh, UK
6 shared publications - Namperumalsamy Venkatesh Prajna
Aravind Eye Care System, Madurai, India
6 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by American Society for Microbiology in Microbiology Spectrum
A microscopy-free approach for detection of fungal elements in tissue using mannan immunoassay
KOH microscopy is a routine method to determine the presence of fungal elements in infected tissue. Although widely used, the procedure requires trained personnel and the infrastructure needed for microscopy. An alternative approach is the extraction of fungal antigens and detection by immunoassay. In this study, we used oxidative release with sodium hypochlorite to extract mannan from fungal cells. Quenching of free sodium hypochlorite was done using an excess of bovine serum albumin or sodium thiosulfate. Quenching reagents were incorporated into sample pads of lateral flow immunoassays (LFIAs), followed by detection of released mannan using mannan-specific monoclonal antibodies coupled to colloidal gold on the LFIA platform. Cells of Candida spp. or Aspergillus spp. were used to evaluate the extraction/quenching steps. The results showed that sodium thiosulfate was particularly well suited for hands-free, in-strip neutralization. The analytical sensitivity (minimum limit of detection, LOD) of the Candida LFIA was 67 ng/mL of formaldehyde-inactivated, whole Candida albicans cells. The LOD of the Aspergillus LFIA was 250 ng/mL of formaldehyde-inactivated, whole Aspergillus fumigatus cells. Proof-of-concept for oxidative release of mannan followed by detection of antigen by LFIA was provided using an ex vivo porcine corneal model of fungal keratitis. The results demonstrated that the test is a rapid two-step, specimen-to-result protocol suitable for point-of-care use. Such a diagnostic would be particularly valuable in settings that lack access to the trained personnel or infrastructure needed for KOH microscopy. IMPORTANCE: KOH microscopy is widely used to detect fungal infection, but it requires trained personnel and microscopy infrastructure. An alternative approach is extraction of antigens from fungal cells within infected tissue and detection by lateral flow immunoassay. In this study, we developed a Candida and Aspergillus tests was evaluated with cultured fungal cells. Clinical proof-of-concept for each assay was provided using an ex vivo porcine corneal model of fungal keratitis. This diagnostic strategy would be particularly valuable in settings that lack access to trained personnel or the infrastructure needed for KOH microscopy.
- 22 October 2026
- Published by American Society for Microbiology in Microbiology Spectrum
Open AccessA microscopy-free approach for detection of fungal elements in tissue using mannan immunoassay
KOH microscopy is a routine method to determine the presence of fungal elements in infected tissue. Although widely used, the procedure requires trained personnel and the infrastructure needed for microscopy. An alternative approach is the extraction of fungal antigens and detection by immunoassay. In this study, we used oxidative release with sodium hypochlorite to extract mannan from fungal cells. Quenching of free sodium hypochlorite was done using an excess of bovine serum albumin or sodium thiosulfate. Quenching reagents were incorporated into sample pads of lateral flow immunoassays (LFIAs), followed by detection of released mannan using mannan-specific monoclonal antibodies coupled to colloidal gold on the LFIA platform. Cells of Candida spp. or Aspergillus spp. were used to evaluate the extraction/quenching steps. The results showed that sodium thiosulfate was particularly well suited for hands-free, in-strip neutralization. The analytical sensitivity (minimum limit of detection, LOD) of the Candida LFIA was 67 ng/mL of formaldehyde-inactivated, whole Candida albicans cells. The LOD of the Aspergillus LFIA was 250 ng/mL of formaldehyde-inactivated, whole Aspergillus fumigatus cells. Proof-of-concept for oxidative release of mannan followed by detection of antigen by LFIA was provided using an ex vivo porcine corneal model of fungal keratitis. The results demonstrated that the test is a rapid two-step, specimen-to-result protocol suitable for point-of-care use. Such a diagnostic would be particularly valuable in settings that lack access to the trained personnel or infrastructure needed for KOH microscopy. IMPORTANCE: KOH microscopy is widely used to detect fungal infection, but it requires trained personnel and microscopy infrastructure. An alternative approach is extraction of antigens from fungal cells within infected tissue and detection by lateral flow immunoassay. In this study, we developed a Candida and Aspergillus tests was evaluated with cultured fungal cells. Clinical proof-of-concept for each assay was provided using an ex vivo porcine corneal model of fungal keratitis. This diagnostic strategy would be particularly valuable in settings that lack access to trained personnel or the infrastructure needed for KOH microscopy.
- Open Access
- 1 October 2026
- Published by Springer Nature in Eye
- p. 1-8
Multidrug antifungal resistance and clinical outcomes in fungal keratitis: a prospective study in a South Indian population
Objectives: Our primary objective was to identify the rate of antifungal resistance (including multidrug resistance) of fungal isolates cultured from fungal keratitis patients in South India. Our secondary objective was to identify associations between antifungal resistance and patient outcome. Subjects/methods: 153 patients attending the cornea clinic at Aravind Eye Hospital, Madurai (May–August 2025) with culture-positive fungal keratitis were enrolled in the study. Cultured isolates were evaluated for natamycin, amphotericin B, voriconazole and econazole minimum inhibitory concentration (MIC; n = 151–153). MIC data were analysed by Kruskal-Wallis test followed by Dunn’s multiple comparisons. Patient disease outcome relative to isolate resistance was analysed by Fisher’s exact test ( n = 91). Results: There were high levels of resistance to all four antifungals, which were significantly elevated in Fusarium spp. and Aspergillus spp. isolates compared to other fungal genera ( P < 0.0001). Fusarium spp. isolates ( n = 81) resistant to: natamycin: 38.3%; amphotericin B: 93.8%; voriconazole: 97.5%; and econazole: 76.5%. Aspergillus spp. isolates ( n = 33) resistant to: natamycin: 66.7%; amphotericin B: 87.9%; voriconazole: 6.1%; and econazole: 0%. Overall, fungal resistance to natamycin significantly correlated with an adverse clinical outcome, P = 0.0034, relative risk 1.7 (95% CI: 1.2–2.6). Conclusions: The majority of fungal isolates were resistant to multiple antifungals; none of the Fusarium isolates were susceptible to all four drugs, and 28% were resistant to all of them. Resistance to natamycin may worsen clinical outcome, particularly for infections caused by Aspergillus, even when susceptible to azoles. Our data support the need for species-specific MIC thresholds to have increased clinical utility.
- 1 October 2026
- Published by Springer Nature in Eye
- p. 1-8
Open AccessMultidrug antifungal resistance and clinical outcomes in fungal keratitis: a prospective study in a South Indian population
Objectives: Our primary objective was to identify the rate of antifungal resistance (including multidrug resistance) of fungal isolates cultured from fungal keratitis patients in South India. Our secondary objective was to identify associations between antifungal resistance and patient outcome. Subjects/methods: 153 patients attending the cornea clinic at Aravind Eye Hospital, Madurai (May–August 2025) with culture-positive fungal keratitis were enrolled in the study. Cultured isolates were evaluated for natamycin, amphotericin B, voriconazole and econazole minimum inhibitory concentration (MIC; n = 151–153). MIC data were analysed by Kruskal-Wallis test followed by Dunn’s multiple comparisons. Patient disease outcome relative to isolate resistance was analysed by Fisher’s exact test ( n = 91). Results: There were high levels of resistance to all four antifungals, which were significantly elevated in Fusarium spp. and Aspergillus spp. isolates compared to other fungal genera ( P < 0.0001). Fusarium spp. isolates ( n = 81) resistant to: natamycin: 38.3%; amphotericin B: 93.8%; voriconazole: 97.5%; and econazole: 76.5%. Aspergillus spp. isolates ( n = 33) resistant to: natamycin: 66.7%; amphotericin B: 87.9%; voriconazole: 6.1%; and econazole: 0%. Overall, fungal resistance to natamycin significantly correlated with an adverse clinical outcome, P = 0.0034, relative risk 1.7 (95% CI: 1.2–2.6). Conclusions: The majority of fungal isolates were resistant to multiple antifungals; none of the Fusarium isolates were susceptible to all four drugs, and 28% were resistant to all of them. Resistance to natamycin may worsen clinical outcome, particularly for infections caused by Aspergillus, even when susceptible to azoles. Our data support the need for species-specific MIC thresholds to have increased clinical utility.
- Open Access
Endomicroscopic fluorescence lifetime imaging enables molecular detection and targeted sampling in the distal human lung
Purpose: Accurate molecular characterisation of infection and inflammation within the distal human lung remains challenging, particularly in critically ill patients, due to limited access to the alveolar space and delayed diagnostic workflows. Molecular imaging approaches capable of real-time detection and targeted sampling could substantially improve diagnostic precision and the future translational development of molecular imaging probes and therapeutics. Methods: In a preclinical setting, we evaluated a clinic-ready endomicroscopic fluorescence lifetime imaging microscopy (eFLIM) platform combined with molecularly targeted SmartProbes for in situ detection of bacteria and activated neutrophils in the distal human lung. A multifunctional 1.9-mm diameter imaging and sampling catheter (Eyes on Target; EoT) enabled real-time fluorescence intensity and lifetime imaging alongside directed alveolar microlavage via a 1.2-mm working channel. Fluorescence intensity and lifetime signatures of Gram-negative bacteria, Gram-positive bacteria, and activated neutrophils were characterised using three wash-free SmartProbes: NBD-PMX, Merocy-Van, and a neutrophil activation probe (NAP). Imaging and sampling performance were assessed in ventilated ex vivo human lungs. Results: EoT reliably navigated to alveolar regions across all lung lobes in both phantom and ventilated human lung models. eFLIM distinguished alveolar microanatomy and enabled probe-specific molecular detection within the distal lung. Increased NBD-PMX signal was detected in Escherichia coli –instilled lobes, while Merocy-Van lifetime signatures selectively identified Staphylococcus aureus –instilled regions. Activated neutrophils were detected throughout lung tissue following NAP administration. Directed alveolar microlavage enabled recovery of cellular material and bacterial DNA from imaged regions for downstream analysis. Conclusion: eFLIM using EoT combined with molecular SmartProbes enables real-time molecular imaging and targeted sampling within the distal human lung. This platform provides a translatable approach for evaluating infection and inflammation at the alveolar level and supports the clinical development of molecular imaging probes for pulmonary disease.
Open AccessEndomicroscopic fluorescence lifetime imaging enables molecular detection and targeted sampling in the distal human lung
Purpose: Accurate molecular characterisation of infection and inflammation within the distal human lung remains challenging, particularly in critically ill patients, due to limited access to the alveolar space and delayed diagnostic workflows. Molecular imaging approaches capable of real-time detection and targeted sampling could substantially improve diagnostic precision and the future translational development of molecular imaging probes and therapeutics. Methods: In a preclinical setting, we evaluated a clinic-ready endomicroscopic fluorescence lifetime imaging microscopy (eFLIM) platform combined with molecularly targeted SmartProbes for in situ detection of bacteria and activated neutrophils in the distal human lung. A multifunctional 1.9-mm diameter imaging and sampling catheter (Eyes on Target; EoT) enabled real-time fluorescence intensity and lifetime imaging alongside directed alveolar microlavage via a 1.2-mm working channel. Fluorescence intensity and lifetime signatures of Gram-negative bacteria, Gram-positive bacteria, and activated neutrophils were characterised using three wash-free SmartProbes: NBD-PMX, Merocy-Van, and a neutrophil activation probe (NAP). Imaging and sampling performance were assessed in ventilated ex vivo human lungs. Results: EoT reliably navigated to alveolar regions across all lung lobes in both phantom and ventilated human lung models. eFLIM distinguished alveolar microanatomy and enabled probe-specific molecular detection within the distal lung. Increased NBD-PMX signal was detected in Escherichia coli –instilled lobes, while Merocy-Van lifetime signatures selectively identified Staphylococcus aureus –instilled regions. Activated neutrophils were detected throughout lung tissue following NAP administration. Directed alveolar microlavage enabled recovery of cellular material and bacterial DNA from imaged regions for downstream analysis. Conclusion: eFLIM using EoT combined with molecular SmartProbes enables real-time molecular imaging and targeted sampling within the distal human lung. This platform provides a translatable approach for evaluating infection and inflammation at the alveolar level and supports the clinical development of molecular imaging probes for pulmonary disease.
- Open Access
Development and evaluation of a pan-fungal lateral flow device for the rapid identification of pathogen class in microbial keratitis
Purpose: To develop a pan-fungal lateral flow device (LFD); evaluating device performance with samples obtained from ex vivo porcine cornea infection models. Methods: Fungal β-glucan (PF1), human CLEC7A/Dectin-1/CLECSF12 protein (Fc Tag; PF2), and fungal melanin (PF3) antibodies were evaluated for binding to clinically relevant fungal and bacterial species ( Aspergillus flavus, Fusarium keratoplasticum, Candida albicans, Pseudomonas aeruginosa, Staphylococcus aureus ) by immunofluorescence staining. PF1 and PF2 were evaluated in proof-of-concept, in-house LFD strips using cultured pathogens and ex vivo porcine corneal infection samples. The lead antibody (PF1) was validated in a commercially-developed prototype LFD. Results: PF1 and PF2 discriminated target fungi from bacteria by immunofluorescence microscopy and in-house LFD strips. The lead candidate PF1 demonstrated good sensitivity (0.75) and specificity (0.94) with cultured fungal hyphae. Samples obtained from infected ex vivo cornea by clinically relevant methods confirmed excellent sensitivity (scrapes: 1.00, swabs: 0.94) and specificity (scrapes: 1.00, swabs: 0.83). The commercially-developed PF1-LFD prototype achieved perfect sensitivity (1.00) and specificity (1.00) when detecting and discriminating fungi from non-fungal ex vivo corneal swab samples. Conclusions: Feasibility of pan-fungal LFD application in microbial keratitis diagnosis was demonstrated – using β-glucan as a pan-fungal target and a clinically relevant microbial keratitis ex vivo model. LFDs were able to differentiate fungal from bacterial samples, detect antigen present in corneal swabs, and provide a read-out within 20 minutes. Sensitivity and specificity values are comparable to currently used diagnostic tests. Translational Relevance: Early discrimination of fungal keratitis cases is important to adapt treatment, and improve patient outcome.
Open AccessDevelopment and evaluation of a pan-fungal lateral flow device for the rapid identification of pathogen class in microbial keratitis
Purpose: To develop a pan-fungal lateral flow device (LFD); evaluating device performance with samples obtained from ex vivo porcine cornea infection models. Methods: Fungal β-glucan (PF1), human CLEC7A/Dectin-1/CLECSF12 protein (Fc Tag; PF2), and fungal melanin (PF3) antibodies were evaluated for binding to clinically relevant fungal and bacterial species ( Aspergillus flavus, Fusarium keratoplasticum, Candida albicans, Pseudomonas aeruginosa, Staphylococcus aureus ) by immunofluorescence staining. PF1 and PF2 were evaluated in proof-of-concept, in-house LFD strips using cultured pathogens and ex vivo porcine corneal infection samples. The lead antibody (PF1) was validated in a commercially-developed prototype LFD. Results: PF1 and PF2 discriminated target fungi from bacteria by immunofluorescence microscopy and in-house LFD strips. The lead candidate PF1 demonstrated good sensitivity (0.75) and specificity (0.94) with cultured fungal hyphae. Samples obtained from infected ex vivo cornea by clinically relevant methods confirmed excellent sensitivity (scrapes: 1.00, swabs: 0.94) and specificity (scrapes: 1.00, swabs: 0.83). The commercially-developed PF1-LFD prototype achieved perfect sensitivity (1.00) and specificity (1.00) when detecting and discriminating fungi from non-fungal ex vivo corneal swab samples. Conclusions: Feasibility of pan-fungal LFD application in microbial keratitis diagnosis was demonstrated – using β-glucan as a pan-fungal target and a clinically relevant microbial keratitis ex vivo model. LFDs were able to differentiate fungal from bacterial samples, detect antigen present in corneal swabs, and provide a read-out within 20 minutes. Sensitivity and specificity values are comparable to currently used diagnostic tests. Translational Relevance: Early discrimination of fungal keratitis cases is important to adapt treatment, and improve patient outcome.
- Open Access
- 28 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17
Lifetime chemical sensor arrays of organic fluorophores for bacterial fingerprinting
The rise of multi-drug resistant bacteria constitutes a global challenge with direct impact on millions of patients worldwide. The identification of bacterial species is essential to avoid unnecessary use of antibiotics and to minimize the emergence of additional resistance; however, there are few chemical strategies to identify resistant species in a rapid and unbiased manner. Cross-reactive arrays combine multiple sensor components to produce distinctive fingerprints for similar targets; herein, we present a cross-reactive sensing array built with long lifetime organic fluorophores. To the best of our knowledge, we synthesize the largest collection to date of bioconjugatable triangulenium fluorophores by including heteroatom and side-chain diversification for spectral and lifetime diversity, as well as water-soluble and orthogonal moieties for peptide tagging and compatibility with biological samples. After optimization, we evolve a four-fluorophore sensor array that correctly assigns all seven ESKAPEE bacterial species by combining their optical signatures. Lifetime chemical sensor arrays will open avenues for concentration-independent, reliable and sensitive optical detection without the need for prior knowledge of molecular targets.
- 28 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17
Open AccessLifetime chemical sensor arrays of organic fluorophores for bacterial fingerprinting
The rise of multi-drug resistant bacteria constitutes a global challenge with direct impact on millions of patients worldwide. The identification of bacterial species is essential to avoid unnecessary use of antibiotics and to minimize the emergence of additional resistance; however, there are few chemical strategies to identify resistant species in a rapid and unbiased manner. Cross-reactive arrays combine multiple sensor components to produce distinctive fingerprints for similar targets; herein, we present a cross-reactive sensing array built with long lifetime organic fluorophores. To the best of our knowledge, we synthesize the largest collection to date of bioconjugatable triangulenium fluorophores by including heteroatom and side-chain diversification for spectral and lifetime diversity, as well as water-soluble and orthogonal moieties for peptide tagging and compatibility with biological samples. After optimization, we evolve a four-fluorophore sensor array that correctly assigns all seven ESKAPEE bacterial species by combining their optical signatures. Lifetime chemical sensor arrays will open avenues for concentration-independent, reliable and sensitive optical detection without the need for prior knowledge of molecular targets.
- Open Access
- 14 April 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Real-time characterisation of microbe-induced inflammation using a novel zebrafish larval corneal injury and infection model
Microbial keratitis (MK) is a major global cause of blindness. Yet, treatment is heavily dependent on antimicrobials with limited options for immunomodulators - despite the critical role of dysregulated immune responses in disease pathogenesis. This gap reflects a critical unmet clinical need and is compounded by the lack of model systems capable of real-time high-resolution immune dynamics analysis. To address this, we developed a zebrafish larvae MK model utilising transgenic zebrafish lines with fluorescently labelled neutrophils, macrophages and basal epithelial cells. Corneal injury triggered rapid immune cell recruitment which was amplified by exposure to pro-inflammatory mediators such as N-formylmethionine-leucyl-phenylalanine (fMLF) and leukotriene B 4 (LTB 4 ). Infection with live bacteria induced robust, sustained neutrophil and macrophage recruitment, marked by increased neutrophil speed and migratory distance. This model enables dynamic in vivo visualization of immune cell dynamics, offering a powerful and scalable platform to accelerate the discovery and screening of novel immunomodulators for MK.
- 14 April 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessReal-time characterisation of microbe-induced inflammation using a novel zebrafish larval corneal injury and infection model
Microbial keratitis (MK) is a major global cause of blindness. Yet, treatment is heavily dependent on antimicrobials with limited options for immunomodulators - despite the critical role of dysregulated immune responses in disease pathogenesis. This gap reflects a critical unmet clinical need and is compounded by the lack of model systems capable of real-time high-resolution immune dynamics analysis. To address this, we developed a zebrafish larvae MK model utilising transgenic zebrafish lines with fluorescently labelled neutrophils, macrophages and basal epithelial cells. Corneal injury triggered rapid immune cell recruitment which was amplified by exposure to pro-inflammatory mediators such as N-formylmethionine-leucyl-phenylalanine (fMLF) and leukotriene B 4 (LTB 4 ). Infection with live bacteria induced robust, sustained neutrophil and macrophage recruitment, marked by increased neutrophil speed and migratory distance. This model enables dynamic in vivo visualization of immune cell dynamics, offering a powerful and scalable platform to accelerate the discovery and screening of novel immunomodulators for MK.
- Open Access
Multidrug Antifungal Resistance and Clinical Outcomes in Fungal Keratitis: A Prospective Study in a South Indian Population
Objectives: Our primary objective was to identify the rate of anti-fungal resistance (including multidrug resistance) of fungal isolates cultured from fungal keratitis patients in South India. Our secondary objective was to identify associations between antifungal resistance and patient outcome. Subjects/Methods: 153 patients attending the cornea clinic at Aravind Eye Hospital, Madurai (May – August 2025) with culture positive fungal keratitis were enrolled in the study. Cultured isolates were evaluated for natamycin, amphotericin B, voriconazole and econazole MIC (n=151-153). MIC data were analysed by Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Patient disease outcome relative to isolate resistance was analysed by fisher’s exact test (n=91). Results: There were high levels of resistance to all four antifungals, which were significantly elevated in Fusarium spp. and Aspergillus spp. isolates compared to other fungal genera (PFusarium spp. isolates (n= 81) to: natamycin: 38.3%; amphotericin B: 93.8%; voriconazole: 97.5% and econazole: 76.5%. Resistance of Aspergillus spp. isolates (n=33) to: natamycin: 66.7%; amphotericin B: 87.9%; voriconazole: 6.1%; and econazole: 0%. Overall, fungal resistance to natamycin significantly correlated with a poor clinical outcome, P=0.0034, relative risk 1.7 (95% CI: 1.2-2.6). Conclusions: The majority of fungal isolates were resistant to multiple antifungals; none of the Fusarium isolates were susceptible to all four drugs, 15% were resistant to all of them. Resistance towards natamycin may worsen clinical outcome, particularly for infections caused by Aspergillus , even when susceptible to azoles. Our data supports the need for species specific MIC thresholds to have increased clinical utility.
Open AccessMultidrug Antifungal Resistance and Clinical Outcomes in Fungal Keratitis: A Prospective Study in a South Indian Population
Objectives: Our primary objective was to identify the rate of anti-fungal resistance (including multidrug resistance) of fungal isolates cultured from fungal keratitis patients in South India. Our secondary objective was to identify associations between antifungal resistance and patient outcome. Subjects/Methods: 153 patients attending the cornea clinic at Aravind Eye Hospital, Madurai (May – August 2025) with culture positive fungal keratitis were enrolled in the study. Cultured isolates were evaluated for natamycin, amphotericin B, voriconazole and econazole MIC (n=151-153). MIC data were analysed by Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Patient disease outcome relative to isolate resistance was analysed by fisher’s exact test (n=91). Results: There were high levels of resistance to all four antifungals, which were significantly elevated in Fusarium spp. and Aspergillus spp. isolates compared to other fungal genera (PFusarium spp. isolates (n= 81) to: natamycin: 38.3%; amphotericin B: 93.8%; voriconazole: 97.5% and econazole: 76.5%. Resistance of Aspergillus spp. isolates (n=33) to: natamycin: 66.7%; amphotericin B: 87.9%; voriconazole: 6.1%; and econazole: 0%. Overall, fungal resistance to natamycin significantly correlated with a poor clinical outcome, P=0.0034, relative risk 1.7 (95% CI: 1.2-2.6). Conclusions: The majority of fungal isolates were resistant to multiple antifungals; none of the Fusarium isolates were susceptible to all four drugs, 15% were resistant to all of them. Resistance towards natamycin may worsen clinical outcome, particularly for infections caused by Aspergillus , even when susceptible to azoles. Our data supports the need for species specific MIC thresholds to have increased clinical utility.
- Open Access
- 1 December 2025
- Published by Springer Nature in Research Square
Real-time Characterisation and modulation of microbe-induced inflammation and resolution, using a novel zebrafish larval corneal injury and infection model
Microbial keratitis (MK) is a major global cause of blindness. Yet, treatment is still heavily dependent on antimicrobials with limited options for immunomodulators - despite the critical role of dysregulated immune responses in disease pathogenesis. This gap reflects a critical unmet clinical need and is compounded by the lack of model systems capable of real-time high-resolution immune dynamics analysis. To address this, we developed a zebrafish larvae MK model utilising transgenic zebrafish lines with fluorescently labelled neutrophils, macrophages and basal epithelial cells. Corneal injury triggered rapid immune cell recruitment which was amplified by exposure to pro-inflammatory mediators such as N-formylmethionine-leucyl-phenylalanine (fMLF) and leukotriene B4 (LTB4). Infection with live bacteria induced robust, sustained neutrophil and macrophage recruitment, marked by increased neutrophil speed and migratory distance. This model enables dynamic in-vivo visualization of immune cell dynamics, offering a powerful and scalable platform to accelerate the discovery and screening of novel immunomodulators for MK.
- 1 December 2025
- Published by Springer Nature in Research Square
Open AccessReal-time Characterisation and modulation of microbe-induced inflammation and resolution, using a novel zebrafish larval corneal injury and infection model
Microbial keratitis (MK) is a major global cause of blindness. Yet, treatment is still heavily dependent on antimicrobials with limited options for immunomodulators - despite the critical role of dysregulated immune responses in disease pathogenesis. This gap reflects a critical unmet clinical need and is compounded by the lack of model systems capable of real-time high-resolution immune dynamics analysis. To address this, we developed a zebrafish larvae MK model utilising transgenic zebrafish lines with fluorescently labelled neutrophils, macrophages and basal epithelial cells. Corneal injury triggered rapid immune cell recruitment which was amplified by exposure to pro-inflammatory mediators such as N-formylmethionine-leucyl-phenylalanine (fMLF) and leukotriene B4 (LTB4). Infection with live bacteria induced robust, sustained neutrophil and macrophage recruitment, marked by increased neutrophil speed and migratory distance. This model enables dynamic in-vivo visualization of immune cell dynamics, offering a powerful and scalable platform to accelerate the discovery and screening of novel immunomodulators for MK.
- Open Access
Trends in aetiology and antibiotic resistance in bacterial keratitis isolates from South India between 2013-2024
Aim: To measure aetiology and antibiotic resistance (AMR) trends of bacteria cultured from corneal scrapings from patients with infectious keratitis at a tertiary referral hospital in South India. Methods: In this retrospective study, bacterial aetiology and antimicrobial resistance profiles were identified from the microbiology records of patients undergoing microbial keratitis diagnosis at the Aravind Eye Hospital, Madurai, India from 2013-2024. Statistical analyses were performed by Spearman’s rank correlation coefficient to identify significant trends. Results: P. aeruginosa (n=1047) was the most frequently isolated bacteria, followed by S. pneumoniae (n=987). There were significant increases in the number of P. aeruginosa (rs: 0.66; P=0.0219) and S. aureus isolates cultured (r s : 0.70; P=0.0130). S. aureus demonstrated increasing resistance to cefazolin (rs: 0.76; P=0.0015), gatifloxacin (rs: 0.75; P=0.0071), levofloxacin (r s : 0.60; P=0.0442), moxifloxacin (r s : 0.59; P=0.0437) and chloramphenicol (r s : 0.78; P=0.0049) over time. S. pneumoniae resistance towards tetracycline significantly increased (r s : 0.80; P=0.0029). P. aeruginosa isolates remained largely susceptible to all antibiotics screened, with significant decreasing resistance rates to ceftazidime (r s : −0.71; P=0.019), amikacin (r s : −0.59; P=0.0489), gentamicin (r s : −0.66; P=0.0219) and tobramycin (r s : −0.69; P=0.017) identified. No significant trends in resistance patterns were identified for Nocardia spp .. Conclusion: Bacterial aetiology and antibiotic resistance rates shifted over time for key pathogens causing keratitis. Understanding these in the local context is important. For instance, while others in India have reported increasing P. aeruginosa AMR, we did not find this to be true in our patient population. This may have implications for local prescribing guidelines. Key Messages: What is already known on this topic: Microbial keratitis remains a highly prevalent, sight-limiting condition in India. Treatment options are limited, and are confounded by emergent antibiotic resistance (AMR) of causative pathogens. What this study adds: This study demonstrates shifting bacterial aetiology, and antimicrobial resistance patterns. Our data on P. aeruginosa resistance patterns contradict other reporting within India, where our resistance rates remained low. How this study might affect research, practice or policy: Fluoroquinolones are the most common first-line treatment for bacterial keratitis, yet over 80% of our S. aureus isolates demonstrated resistance towards fluoroquinolones in 2024. Understanding local and temporal bacterial aetiology and resistance rates are imperative for designing local guidelines for patient treatment practices.
Open AccessTrends in aetiology and antibiotic resistance in bacterial keratitis isolates from South India between 2013-2024
Aim: To measure aetiology and antibiotic resistance (AMR) trends of bacteria cultured from corneal scrapings from patients with infectious keratitis at a tertiary referral hospital in South India. Methods: In this retrospective study, bacterial aetiology and antimicrobial resistance profiles were identified from the microbiology records of patients undergoing microbial keratitis diagnosis at the Aravind Eye Hospital, Madurai, India from 2013-2024. Statistical analyses were performed by Spearman’s rank correlation coefficient to identify significant trends. Results: P. aeruginosa (n=1047) was the most frequently isolated bacteria, followed by S. pneumoniae (n=987). There were significant increases in the number of P. aeruginosa (rs: 0.66; P=0.0219) and S. aureus isolates cultured (r s : 0.70; P=0.0130). S. aureus demonstrated increasing resistance to cefazolin (rs: 0.76; P=0.0015), gatifloxacin (rs: 0.75; P=0.0071), levofloxacin (r s : 0.60; P=0.0442), moxifloxacin (r s : 0.59; P=0.0437) and chloramphenicol (r s : 0.78; P=0.0049) over time. S. pneumoniae resistance towards tetracycline significantly increased (r s : 0.80; P=0.0029). P. aeruginosa isolates remained largely susceptible to all antibiotics screened, with significant decreasing resistance rates to ceftazidime (r s : −0.71; P=0.019), amikacin (r s : −0.59; P=0.0489), gentamicin (r s : −0.66; P=0.0219) and tobramycin (r s : −0.69; P=0.017) identified. No significant trends in resistance patterns were identified for Nocardia spp .. Conclusion: Bacterial aetiology and antibiotic resistance rates shifted over time for key pathogens causing keratitis. Understanding these in the local context is important. For instance, while others in India have reported increasing P. aeruginosa AMR, we did not find this to be true in our patient population. This may have implications for local prescribing guidelines. Key Messages: What is already known on this topic: Microbial keratitis remains a highly prevalent, sight-limiting condition in India. Treatment options are limited, and are confounded by emergent antibiotic resistance (AMR) of causative pathogens. What this study adds: This study demonstrates shifting bacterial aetiology, and antimicrobial resistance patterns. Our data on P. aeruginosa resistance patterns contradict other reporting within India, where our resistance rates remained low. How this study might affect research, practice or policy: Fluoroquinolones are the most common first-line treatment for bacterial keratitis, yet over 80% of our S. aureus isolates demonstrated resistance towards fluoroquinolones in 2024. Understanding local and temporal bacterial aetiology and resistance rates are imperative for designing local guidelines for patient treatment practices.
- Open Access
- 23 July 2025
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 196 (Pt B) , 110678
EmiNet: Moving bacteria detection on optical endomicroscopy images trained on synthetic data
- 23 July 2025
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 196 (Pt B) , 110678
Open AccessEmiNet: Moving bacteria detection on optical endomicroscopy images trained on synthetic data